SOLIGENIX, INC.SNGXEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare diseases, unmet medical needs in inflammatory disorders, and prophylactic vaccines for biodefense use cases. It operates primarily in the U.S. and global biotech markets, serving patient groups underserved by existing standard care options.